Despite the small sample size (n = 18) limiting generalizability, this approach enabled deep profiling in a resource-limited setting and revealed candidate biomarkers (e.g., thrombospondin-1 and STXBP5) and pathways (e.g., complement and TGF-β) for severe dengue. This evidence concerns the gene STXBP5 and dengue disease.